Chandler, AZ, United States of America

Zhuping Ma

This inventor holds 1 USPTO granted patent. Top assignee: Bristol-Myers Squibb Compnay. Active years: 2006.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Zhuping Ma. Retrieved from https://idiyas.com/inventor/zhuping-ma

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 8.0

ph-index = 1

Forward Citations = 15(Granted Patents)


Company Filing History:


Years Active: 2006

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Zhuping Ma - Innovator in HIV Research

Introduction

Zhuping Ma is a notable inventor based in Chandler, AZ (US). He has made significant contributions to the field of HIV research, particularly through his innovative work on integrase inhibitors.

Latest Patents

Zhuping Ma holds 1 patent related to his research. His patent focuses on HIV integrase inhibitors, describing novel compounds of Formula I that inhibit HIV integrase. The invention also outlines compositions and treatments for AIDS or ARC utilizing these compounds.

Career Highlights

Zhuping Ma is currently associated with Bristol-Myers Squibb Company, where he continues to advance his research in the pharmaceutical field. His work has the potential to impact the treatment of HIV significantly.

Collaborations

Throughout his career, Zhuping Ma has collaborated with esteemed colleagues, including Michael A. Walker and B. Narasimhulu Naidu. These collaborations have further enriched his research and development efforts.

Conclusion

Zhuping Ma's contributions to HIV research through his innovative patents and collaborations highlight his role as a key figure in the fight against this disease. His work continues to pave the way for advancements in treatment options.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…